In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation

BACKGROUND: COVID‐19 is associated with a substantial risk of venous thrombotic events, even in the presence of adequate thromboprophylactic therapy. OBJECTIVES: We aimed to better characterize the hypercoagulable state of COVID‐19 patients in patients receiving anticoagulant therapy. METHODS: We to...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasi, Annabel, von Meijenfeldt, Fien A., Adelmeijer, Jelle, Calvo, Andrea, Ibañez, Cristina, Perdomo, Juan, Reverter, Juan C., Lisman, Ton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436627/
https://www.ncbi.nlm.nih.gov/pubmed/32762118
http://dx.doi.org/10.1111/jth.15043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436627/
https://www.ncbi.nlm.nih.gov/pubmed/32762118
http://dx.doi.org/10.1111/jth.15043

Ejemplares similares